Lysyl oxidase and adipose tissue dysfunction.

BACKGROUND/OBJECTIVES Lysyl oxidase (LOX) is an enzyme crucial for collagen fibre crosslinking and thus for fibrosis development. Fibrosis is characterised by a surplus of collagen fibre accumulation and is amongst others also a feature of obesity-associated dysfunctional adipose tissue (AT) which has been linked with type 2 diabetes. We hypothesised that in type 2 diabetes and obesity LOX expression and activity will be increased as a consequence of worsening AT dysfunction. This study aimed to provide a comprehensive characterisation of LOX in human AT. METHODS LOX mRNA expression was analysed in omental and abdominal subcutaneous AT obtained during elective surgery from subjects with a wide range of BMI, with and without diabetes. In addition, LOX expression was studied in subcutaneous AT before and 9.5months after bariatric surgery. To study the mechanism of LOX changes, its expression and activity were assessed after either hypoxia, recombinant human leptin or glucose treatment of AT explants. In addition, LOX response to acute inflammation was tested after stimulation by a single injection of lipopolysaccharide versus saline solution (control) in healthy men, in vivo. Quantity of mRNA was measured by RT-qPCR. RESULTS LOX expression was higher in obesity and correlated with BMI whilst, in vitro, leptin at high concentrations, as a potential feedback mechanism, suppressed its expression. Neither diabetes status, nor hyperglycaemia affected LOX. Hypoxia and lipopolysaccharide-induced acute inflammation increased LOX AT expression, latter was independent of macrophage infiltration. CONCLUSIONS Whilst LOX may not be affected by obesity-associated complications such as diabetes, our results confirm that LOX is increased by hypoxia and inflammation as underlying mechanism for its upregulation in adipose tissue with obesity.

[1]  J. Mauer,et al.  IL-6 Regulates M2 Polarization and Local Proliferation of Adipose Tissue Macrophages in Obesity , 2017, The Journal of Immunology.

[2]  K. Clément,et al.  Human adipocyte function is impacted by mechanical cues , 2014, The Journal of pathology.

[3]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[4]  K. Kos,et al.  GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction. , 2017, Clinical science.

[5]  M. Weedon,et al.  An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy , 2013, Nature Genetics.

[6]  K. Clément,et al.  Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. , 2014, The Journal of clinical endocrinology and metabolism.

[7]  Jean-Daniel Zucker,et al.  Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass Loss , 2010, Diabetes.

[8]  J. Mäki.  Lysyl oxidases in mammalian development and certain pathological conditions. , 2009, Histology and histopathology.

[9]  P. Bonaldo,et al.  Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. , 2014, American journal of physiology. Endocrinology and metabolism.

[10]  K. Clément,et al.  Accumulation and Changes in Composition of Collagens in Subcutaneous Adipose Tissue After Bariatric Surgery. , 2016, The Journal of clinical endocrinology and metabolism.

[11]  N. Musi,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[12]  L. Partridge,et al.  Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin , 2014, Nature Immunology.

[13]  V. Vallon.  The proximal tubule in the pathophysiology of the diabetic kidney. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  N. Moustaid‐Moussa,et al.  Culture of adipose tissue and isolated adipocytes. , 2001, Methods in molecular biology.

[15]  Alexandra R. Washabaugh,et al.  Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity , 2016, Obesity.

[16]  K. Kos,et al.  Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity. , 2017, Diabetes & metabolism.

[17]  Isabel Azevedo,et al.  Chronic Inflammation in Obesity and the Metabolic Syndrome , 2010, Mediators of inflammation.

[18]  K. Clément,et al.  Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity , 2008, Genome Biology.

[19]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[20]  M. Rudemo,et al.  Identification of adipocyte genes regulated by caloric intake. , 2010, The Journal of clinical endocrinology and metabolism.

[21]  K. Clément,et al.  Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. , 2009, Molecular endocrinology.

[22]  Lianwen Qi,et al.  The role of metformin and resveratrol in the prevention of hypoxia‐inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue , 2016, British journal of pharmacology.

[23]  K. Kos,et al.  COL6A3 is regulated by leptin in human adipose tissue and reduced in obesity. , 2015, Endocrinology.

[24]  N. Møller,et al.  Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial , 2016, PloS one.

[25]  A. Attie,et al.  Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue , 2009, Molecular and Cellular Biology.

[26]  Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. , 2015, Sleep.

[27]  R. Harris.  Direct and indirect effects of leptin on adipocyte metabolism. , 2014, Biochimica et biophysica acta.

[28]  Jay Snoddy,et al.  Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. , 2004, The Journal of nutrition.

[29]  Bohan Wang,et al.  Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? , 2008, British Journal of Nutrition.

[30]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  Arantxa González,et al.  Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. , 2010, American journal of physiology. Heart and circulatory physiology.

[32]  A. Vidal-Puig,et al.  Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues , 2016, Diabetologia.

[33]  D. Davis,et al.  Identification of functional hypoxia inducible factor response elements in the human lysyl oxidase gene promoter. , 2017, Biochemical and biophysical research communications.

[34]  K. Clément,et al.  Fibrosis and adipose tissue dysfunction. , 2013, Cell metabolism.

[35]  Neil Liversedge,et al.  The mechanical properties of human adipose tissues and their relationships to the structure and composition of the extracellular matrix. , 2013, American journal of physiology. Endocrinology and metabolism.

[36]  T. Tian,et al.  Hypoxia triggers angiogenesis by increasing expression of LOX genes in 3‐D culture of ASCs and ECs , 2017, Experimental cell research.

[37]  K. Tsuneyama,et al.  Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice , 2013, Diabetologia.

[38]  P. Scherer,et al.  Selective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction , 2012, Molecular and Cellular Biology.

[39]  M. Luaces,et al.  The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats , 2015, Disease Models & Mechanisms.

[40]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[41]  Philipp E. Scherer,et al.  Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.

[42]  Frédéric Dayan,et al.  The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. , 2011, Cancer research.

[43]  M. Anselmino,et al.  Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass , 2014, Surgical Endoscopy.

[44]  P. Vitti,et al.  Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects , 2013, International Journal of Obesity.

[45]  Bohan Wang,et al.  PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes , 2008, Biochemical and biophysical research communications.

[46]  J. Pouysségur,et al.  Oxygen, a source of life and stress , 2007, FEBS letters.

[47]  D. Langin,et al.  Comparison of Early (2 Days) and Later (28 Days) Response of Adipose Tissue to Very Low-Calorie Diet in Obese Women. , 2016, The Journal of clinical endocrinology and metabolism.

[48]  H. Kagan,et al.  Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. , 1994, Pathology, research and practice.

[49]  C. Peterson,et al.  Adipose tissue macrophages in insulin resistant subjects are 1 associated with collagen VI, fibrosis and demonstrate 2 alternative activation , 2010 .

[50]  Qifu Li,et al.  AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity , 2016, Diabetes.